|
|
|
Insider
Information: |
Olson William C |
Relationship: |
Senior VP, Research an... |
City: |
Tarrytown |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
45,544 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$186,730 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
45,544 |
|
|
Total
Value |
$186,730 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Progenics Pharmaceuticals Inc |
PGNX |
Senior VP, Research an... |
2012-06-20 |
45,544 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2006-10-02 |
4 |
OE |
$19.58 |
$7,773 |
D/D |
397 |
24,323 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2007-01-03 |
4 |
OE |
$21.88 |
$7,921 |
D/D |
362 |
24,374 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2007-04-02 |
4 |
OE |
$20.13 |
$7,931 |
D/D |
394 |
24,496 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2007-07-02 |
4 |
OE |
$18.71 |
$28,926 |
D/D |
1,546 |
34,071 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2007-10-01 |
4 |
OE |
$19.03 |
$8,868 |
D/D |
466 |
33,180 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2007-12-03 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
28,756 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2008-01-02 |
4 |
OE |
$15.33 |
$8,738 |
D/D |
570 |
33,387 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2008-04-01 |
4 |
OE |
$6.52 |
$10,276 |
D/D |
1,576 |
34,613 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2008-07-01 |
4 |
OE |
$13.64 |
$31,317 |
D/D |
2,296 |
32,044 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2008-10-01 |
4 |
OE |
$6.53 |
$9,691 |
D/D |
1,484 |
38,615 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2009-01-02 |
4 |
OE |
$9.13 |
$11,750 |
D/D |
1,287 |
38,998 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2009-04-01 |
4 |
OE |
$5.65 |
$11,379 |
D/D |
2,014 |
38,177 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2009-10-01 |
4 |
OE |
$4.26 |
$10,788 |
D/D |
2,533 |
39,215 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2010-01-04 |
4 |
OE |
$3.78 |
$11,307 |
D/D |
2,989 |
40,147 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2010-04-01 |
4 |
OE |
$4.56 |
$11,344 |
D/D |
2,490 |
40,124 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
|
2010-07-01 |
4 |
OE |
$4.44 |
$11,282 |
D/D |
2,541 |
38,274 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
|
2010-10-01 |
4 |
OE |
$4.32 |
$29,859 |
D/D |
6,915 |
53,125 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
|
2011-01-03 |
4 |
OE |
$4.83 |
$12,466 |
D/D |
2,582 |
49,655 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
|
2011-04-01 |
4 |
OE |
$5.05 |
$11,984 |
D/D |
2,373 |
49,921 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
Senior VP, Research and Develo |
|
2011-07-01 |
4 |
OE |
$5.46 |
$34,589 |
D/D |
6,335 |
51,609 |
0 |
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research and Development |
|
2005-06-21 |
4 |
S |
$20.00 |
$13,000 |
D/D |
(650) |
13,111 |
|
- |
|
PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
|
2010-06-22 |
4 |
S |
$5.81 |
$13,723 |
D/D |
(2,364) |
35,494 |
0 |
- |
|
72 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|